articles about respiratory

Oral vaccines against respiratory diseases: activating the common mucosal immune system
Oral vaccination in pigs, previously limited to enteric pathogens, is emerging as an innovative strategy against respiratory diseases. By building on the potential of the Common Mucosal Immune System (CMIS), new formulations can trigger immune responses in distant mucosal sites starting from the gut.

Activation of the common mucosal immune system by oral vaccine
By exploring the mechanisms of the Common Mucosal Immune System (CMIS), orally administered vaccines are capable of activating coordinated immune responses across different mucosal sites in the body. In this content, we explain how local activation in the GALT triggers protective effects in distant mucosal tissues, such as the respiratory tract, thereby expanding the reach of immune protection.

NOVUS and Resilient Biotics Partnering on New Swine Health Solution
Both companies are dedicated to creating a product that will provide consistent, measurable benefits.
Can environmental nebulization of lavender essential oil improve welfare and modulate nasal microbiota of growing pigs?

Ceva receives EU marketing authorization granted by the EU Commission for Cirbloc® M Hyo, a new Ready To Use vaccine to protect pigs against PCV2 and Mycoplasma hyopneumoniae
The new vaccine is based on the PCV2d genotype, the most circulating one in the field and on the Mycoplasma hyopneumoniae (M. hyo) strain BA 2940.

Necropsy Manual: Examining organs (I)
In the fourth installment of the manual, we address examining the thoracic cavity organs.

Boehringer Ingelheim presented SoundTalks® powered by FARMERA™
The SoundTalks® Innovation Exchange symposium brought together different stakeholders to share practical applications of digitalisation on farms, especially in the area of respiratory health monitoring.

Boehringer Ingelheim steps forward with new technology to improve respiratory health management in production systems
The global launch of “SoundTalks® powered by FARMERATM” will take place on September 9 in Bologna. This innovative solution enables you to identify trends and patterns at system level and to continuously improve your production system performance 24/7.

Impact of porcine enzootic pneumonia and pleuropneumonia on carcass weight and lean meat content
One percentage of affected lung volume was associated with a 0.24% reduction in lean meat content.

The role of non-progressive atrophic rhinitis: Looking beyond the snout
How do turbinate atrophy and the effect on cilia caused by B. bronchiseptica affect the incidence of S. suis and porcine respiratory disease complex?

Productive and economic impact of pig lung lesions detected at slaughter
Detection of lung lesions in slaughtered pigs also allows estimation of economic losses.

Laboratory diagnostics: Actinobacillus pleuropneumoniae (APP)
What laboratory diagnostic methods can I use to APP? Which one should I choose according to the situation? How do I interpret the results?

Pharmgate: Aivlosin® WSG now approved for use in reproducing sows
Control SRD efficiently in sows with solutions from Pharmgate Animal Health.

The impact of discontinuing perinatal antibiotic treatments in piglets
Side effects of perinatal medications on the microbiota can be detrimental to animal health.